Gland Pharma

Hyderabad, IndiaUnclaimed profile

9Medicines listed

9Certifications

8Facilities

7Export markets

Established in 1978, Gland Pharma is a leading generic injectables manufacturer with operations across 60 countries. The company specializes in sterile injectables, oncology, and ophthalmics with FDA-approved facilities and CDMO capabilities.

Certifications & registrations

WHO-GMPFormulation manufacturingUnverified

FDA RegisteredFormulation manufacturing facilitiesUnverified

EU GMPOncology facilityUnverified

ANVISAFormulation manufacturingBrazil National Health Surveillance AgencyUnverified

TGAFormulation manufacturingTherapeutic Goods Administration AustraliaUnverified

CertificationFormulation manufacturingUnverified

CertificationFormulation manufacturingUK Medicines and Health products Regulatory AgencyUnverified

CertificationFormulation manufacturingBehörde für Gesundheit und Verbraucherschutz – HamburgUnverified

CertificationFormulation manufacturingMedicines Control Council South AfricaUnverified

Medicines & products

Rocuronium Bromide InjectionRocuronium Bromide

Anesthetic · injection

Registered in 8 markets

Rocuronium Bromide Injection

Anesthetics · Injection

Registered in 8 markets

Enoxaparin Sodium InjectionEnoxaparin Sodium

Anti-Coagulant · injection

Registered in 8 markets

Heparin Sodium InjectionHeparin Sodium

Anti-Coagulant · injection

Registered in 8 markets

Enoxaparin Sodium Injection

Anti-Coagulants · Injection

Registered in 8 markets

Heparin Sodium Injection

Anti-Coagulants · Injection

Registered in 8 markets

Daptomycin InjectionDaptomycin

Anti-Infective · injection

Registered in 8 markets

Daptomycin Injection

Anti-Infectives · Injection

Registered in 8 markets

Azithromycin

Antibiotics

Product list is informational, aggregated from public sources — availability is confirmed per-deal through verified offers, not public listings.

Documents & downloads

Corporate BrochurePDF · provided by Gland Pharma

Capabilities

Dosage forms

AmpoulesBagsLiquid vialsLyophilized vialsOphthalmic dropsPre-filled syringes

Therapeutic areas

AnestheticsAnti-CoagulantsAnti-InfectivesAnti-MalarialsCardiologyFertility SupplementsGnRH Agonists and AntagonistsHormones and Related DrugsOncologyOphthalmic

Services

API manufacturingCDMO servicesFormulation developmentTechnology transfer

Export markets

United States United Kingdom Germany Brazil Australia South Africa Canada

Facilities

Dundigal Formulation Facility

Survey No. 143-148, 150 & 151 Near Gandimaisamma 'X' Roads D.P. Pally, Dundigal, Hyderabad, India

GMP USFDA approved since 2003

Pashamylaram Formulation Facility

Plot No. 11 & 84, TSIIC Phase: IV Pashamylaram (V), Patancheru (M), Sangareddy District, Hyderabad, India

GMP USFDA approved April 2016

Penems Facility

Hyderabad, India

GMP USFDA approved April 2016

Oncology Facility SEZ

Visakhapatnam, India

GMP USFDA and EU GMP approved 2014

Visakhapatnam API Facility 1

Visakhapatnam, India

Visakhapatnam API Facility 2

Visakhapatnam, India

Dundigal R&D Pilot Plant

Hyderabad, India

Genome Valley Biotech Drug Substance Facility

Hyderabad, India

Facility & product gallery

Gland Pharma Therapeutic Coverage Products

Sourcing from Gland Pharma through PharmaGlobal

01Submit your requirement

Product, quantity, destination, and documents — in any of 23 languages.

02We review first

Every requirement passes a first-look review before any supplier exposure.

03Compare verified offers

Price, lead time, documents, and risk — side by side in a private deal room.

Data sources: Company disclosures. Last updated June 11, 2026. Profile data is aggregated from public regulatory registries and company disclosures. PharmaGlobal provides sourcing workflow tools; participants remain responsible for their own regulatory and trade compliance. Inaccurate? Report a correction.